Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of pediatric asthma drug budesonide

A compound and solvent technology, applied in the field of drug preparation, can solve the problems of long synthesis route, low overall reaction yield, uneconomical and reasonable overall route, etc., and achieves convenient and simple post-processing, high enantioselectivity, Split effect ideal effect

Inactive Publication Date: 2020-03-27
HEILONGJIANG UNIV OF CHINESE MEDICINE
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Above-mentioned method one is that synthetic route is longer, needs the reaction of at least five steps, the total yield of reaction is low, uses expensive or highly toxic reagent in the reaction process, on the other hand, in above-mentioned preparation process all is to split R and S configuration, so that the S configuration has been reacted until the last step before being separated, the overall route is not economical and reasonable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of pediatric asthma drug budesonide
  • Preparation method of pediatric asthma drug budesonide
  • Preparation method of pediatric asthma drug budesonide

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] step 1):

[0029] In a 10L three-necked flask, add 3L of 1-butyl-3-methylimidazolium bisulfate ([BMIM]HSO 4 ) and 2L of dichloromethane, 40g (0.56mol) of n-butyraldehyde and 208g (0.5mol) of compound I were added, and the reaction was stirred at 30°C for 10h, and the reaction was monitored by TLC until the reaction was complete. The reaction solution was directly concentrated under reduced pressure until no liquid flowed out, and a large amount of white solid was precipitated, which was suction filtered. The filtrate is mainly ionic liquid, which can be recycled directly. The filter cake was rinsed with dichloromethane (200ml) to obtain 231.9g (98.7% yield) of a white solid, and the ratio of its isomers R and S was 85:15.

[0030] Step (2):

[0031] Add 150 g (0.32 mol) of compound II, 5 L of absolute ethanol and 1 L of dichloromethane into a 10 L three-neck flask, stir and dissolve at room temperature. Add 160g (+)-camphorsulfonic acid (0.69mol), heat to 50°C, the ...

Embodiment 2

[0037] step 1):

[0038] In a 10L three-necked flask, add 6L of N-ethylpyridine bisulfate ([EPy]HSO 4 ) and 1L of dichloromethane, added 40g (0.56mol) of n-butyraldehyde and 208g (0.5mol) of compound I, stirred and reacted at 30°C for 5h, and monitored the reaction by TLC until the reaction was complete. The reaction solution was directly concentrated under reduced pressure until no liquid flowed out, and a large amount of white solid was precipitated, which was suction filtered. The filtrate is mainly ionic liquid, which can be recycled directly. The filter cake was rinsed with dichloromethane (200ml) to obtain 223.7g (95.2% yield) of a white solid, and the ratio of isomers R and S was 87:13.

[0039] Step (2):

[0040] Add 150 g (0.32 mol) of compound II, 5 L of absolute ethanol and 1 L of dichloromethane into a 10 L three-neck flask, stir and dissolve at room temperature. Add 120g (+)-tartaric acid (0.8mol), heat to 40°C, the solid disappears completely, and keep the re...

Embodiment 3

[0046] step 1):

[0047] In a 10L three-necked flask, add 3L tetraethylammonium bisulfate ([TEAm]HSO 4 ) and 2L of dichloromethane, 40g (0.56mol) of n-butyraldehyde and 208g (0.5mol) of compound I were added, and the reaction was stirred at 50°C for 4h, and the reaction was monitored by TLC until the reaction was complete. The reaction solution was directly concentrated under reduced pressure until no liquid flowed out, and a large amount of white solid was precipitated, which was suction filtered. The filtrate is mainly ionic liquid, which can be recycled directly. The filter cake was rinsed with dichloromethane (400ml) to obtain 227.7g (96.9% yield) of a white solid, and the ratio of isomers R and S was 89:11.

[0048] Step (2):

[0049] Add 150 g (0.32 mol) of compound II, 5 L of absolute ethanol and 1 L of chloroform into a 10 L three-neck flask, stir and dissolve at room temperature. Add 160g (+)-camphorsulfonic acid (0.69mol), heat to 40°C, the solid disappears compl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of an infantile asthma drug budesonide. The method comprises the following step: carrying out a condensation reaction on a compound I as a raw material andn-butanal, wherein an acidic ionic liquid is taken as a catalyst and a solvent during the condensation reaction. Compared with conventional inorganic catalysts such as hydrochloric acid, sulfuric acid and perchloric acid, the reaction yield and the enantio-selectivity can be improved. The post-treatment is more convenient and simple, too. Meanwhile, a reaction of hydroxyl on locus 11 and butyraldehyde is avoided to generate side products as the ketone carboxyl on the locus 11 is reduced first. After the condensation reaction with butyraldehyde, unnecessary S configuration can be separated andremoved first by splitting, so that the follow-up reaction and treatment costs are saved. The splitting effect of the steps is also relatively ideal. The preparation method is simple in step, high inyield, high in enantio-selectivity and low in cost, and is suitable for industrial production on a large scale.

Description

technical field [0001] The invention relates to a preparation method of medicine, in particular to a preparation method of budesonide, an asthma medicine for children. Background technique [0002] Budesonide was developed by AstraZeneca Pharmaceutical Co., Ltd. and launched in 1981. It is an acetal non-halogenated glucocorticoid drug with strong anti-inflammatory effect, which can inhibit early bronchospasm and late allergic reaction. Its anti-inflammatory activity is 1,000 times that of hydrocortisone, stronger than beclomethasone dipropionate and other glucocorticoids, has a long acting time and rarely produces systemic side effects of adrenal corticosteroids, so it has a comparative advantage among similar drugs. High local or systemic effect ratio, more suitable for local drug use, with the characteristics of small dosage, high curative effect, and small side effects, especially suitable for children, it is used for aerosol inhalation to treat asthma and nasal spray to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07J71/00
CPCC07J71/0031
Inventor 陈宏陈群隋博文刘征栾俊琦赵文成孙洪强
Owner HEILONGJIANG UNIV OF CHINESE MEDICINE